Skip to main navigation Skip to search Skip to main content

Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma

  • Cheng Lung Hsu
  • , Kai Ping Chang
  • , Chien Yu Lin
  • , Hsien Kun Chang
  • , Cheng Hsu Wang
  • , Tung Liang Lin
  • , Chun Ta Liao
  • , Ngan Ming Tsang
  • , Li Yu Lee
  • , Sheng Chieh Chan
  • , Shu Hang Ng
  • , Hsin Pai Li
  • , Yu Sun Chang
  • , Hung Ming Wang*
  • *Corresponding author for this work
  • Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

61 Scopus citations

Abstract

Background To investigate the pretreatment copy number and the clearance rate of plasma Epstein-Barr virus (EBV) DNA as novel prognostic outcome markers for metastatic nasopharyngeal carcinoma (NPC). Methods Seventy-three patients with metastatic NPC were treated at outpatient department. Plasma EBV DNA concentrations and half-life values of plasma viral clearance rates, were determined by real-time quantitative polymerase chain reaction. Results Treatment response evaluated after 3 to 6 months of treatment showed that the overall response rate was 53.5%. The pretreatment plasma EBV DNA concentrations and the half-life of plasma EBV DNA clearance rates had significant effects on treatment response and overall survival prediction. In the chemotherapy regimen, gemcitabine plus cisplatin had a better treatment outcome than the cisplatin plus oral UFT and calcium folinate-based regimens. Conclusions The pretreatment plasma EBV DNA copy number and their clearance rates are significant predictors for NPC treatment outcome. © 2011 Wiley Periodicals, Inc. Head Neck, 2012

Original languageEnglish
Pages (from-to)1064-1070
Number of pages7
JournalHead and Neck
Volume34
Issue number8
DOIs
StatePublished - 08 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • DNA
  • chemotherapy
  • epstein-barr virus
  • head and neck cancer
  • nasopharyngeal cancer

Fingerprint

Dive into the research topics of 'Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma'. Together they form a unique fingerprint.

Cite this